| CAS ID: | 50-23-7 |
| Molecular Formula: | C21H30O5 |
| Molecular Weight: | 362.4 g/mol |
| Monoisotopic Mass: | 362.209 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 | See All |
| InChI Key: | JYGXADMDTFJGBT-VWUMJDOOSA-N | |
| Smiles: | CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01079143 | Disease | Renal fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | March 2, 2010 | Last Verified | March 18, 2014 |
| Sponsor | Novartis Pharmaceuticals | ||
Trial Record 2
| ClinicalTrial ID | NCT02714543 | Disease | Submucous fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | March 21, 2016 | Last Verified | March 21, 2016 |
| Sponsor | The Oxford Dental College, Hospital and Research Center, Bangalore, India | ||
Trial Record 3
| ClinicalTrial ID | NCT00657306 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Unknown |
| First Received | April 14, 2008 | Last Verified | April 14, 2008 |
| Sponsor | University of Turin, Italy | ||
Trial Record 4
| ClinicalTrial ID | NCT02602210 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | November 11, 2015 | Last Verified | October 1, 2018 |
| Sponsor | Universitaire Ziekenhuizen Leuven | ||
| PubChem: | 5754 |
| ChEMBL: |